Omega-3 para niños

OMEGA-3 DHA CONTRIBUYE A MANTENER EL FUNCIONAMIENTO DEL CEREBRO*.
LA VITAMINA D ES NECESARIA PARA EL CRECIMIENTO Y EL DESARROLLO NORMALES DE LOS HUESOS EN LOS NIÑOS.

*DHA (ácido docosahexaenoico). El efecto beneficioso se obtiene con una ingesta diaria de 250 mg de DHA.

Complemento alimenticio diario a base de:

  • Vitamina D3
  • Sin azúcar (con edulcorantes)

Om3gafortSCC utiliza ácidos grasos poliinsaturados Omega-3 EPA/DHA de ALTA CONCENTRACIÓN, EFICACIA, PUREZA y SEGURIDAD obtenidos con una tecnología ECOLÓGICA conocida como Supercritical Concentration (SCC).

COMPOSICIÓN

INFORMACIÓN NUTRICIONAL
Dosis diaria recomendada: 1 gominola.

1 gominola % CDR*
Ácidos grasos omega-3# 400 mg **
EPA (ácido eicosapentaenoico) 105 mg **
DHA (ácido docosahexaenoico) 255 mg **
Otros omega-3 40 mg **
Otros ingredientes principales  **
Vitamina D3 5 µg 100%

*Cantidades diarias recomendadas establecidas por la Directiva 2008/100/CE del 28 de octubre de 2008.
**Cantidad diaria recomendada no establecida.
#Cantidad mínima garantizada en mg de ingrediente activo. Los porcentajes calculados sobre la cantidad mínima en mg son susceptibles de variaciones entre sí.

INGREDIENTES:

Aceite de pescado, edulcorante: Xilitol (E-967), Agua purificada, Edulcorante: sorbitol (E-420), Gelatina, Corrector de acidez: Citrato trisódico (E-331), Acidulante: Ácido málico (E-296), Aroma natural de limón, Vitamina D3 (Colecalciferol), Colorante: 30% Betacaroteno (E-160a).

Mayor concentración, mayor eficacia

  1. Gil-Campos M, Dalmau Serra J; Comité de Nutrición de la Asociación Española de Pediatría. [Importance of docosa­hexaenoic acid (DHA): Functions and recommendations for its ingestion in infants]. An Pediatr (Barc). 2010 Sep;73(3):142.e1-8.
  2. Nyaradi A, Li J, Hickling S, et al. The role of nutrition in children’s neurocognitive development, from pregnancy through childhood. Front Hum Neurosci. 2013 Mar 26;7:97.
  3. Richardson A. Background to the DOLAB Studies: Omega-3 and Child Behaviour and Learn­ing. Omega-3 DHA and Children’s Behaviour and Learning: New Insights from the ‘DOL AB’ Studies. 4 September 2013 – The Royal College of Surgeons, London.
  4. Kuratko CN, Barrett EC, Nelson EB, Salem N Jr. The relationship of docosahexae­noic acid (DHA) with learning and behavior in healthy children: a review. Nutrients. 2013 Jul 19;5(7):2777-2810.
  5. Willatts P, Forsyth S, Agostoni C, et al. Effects of long-chain PUFA supplementation in infant formula on cognitive function in later childhood. Am J Clin Nutr. 2013 Aug;98(2):536S-542S.
  6. Colom­bo J, Carlson SE, Cheatham CL, et al. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr. 2013Aug;98(2):403-412.
  7. McNamara RK, Able J, Jandacek R, et al. Docosahexaenoic acid supplementation increases prefrontal cor­tex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr. 2010;91:1060-1067.
  8. Montgomery P, Burton JR, Sewell RP, et al. Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the DOLAB study. PLoS One. 2013 Jun 24;8(6):e66697.
  9. Richardson AJ, Burton JR, Sewell RP, et al. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One 2012;7(9):e43909.
  10. Dalton A, Wolmarans P, Witthuhn RC, et al. A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fatty Acids. 2009;80:143-9.
  11. Birch EE, Carlson SE, Hoffman DR, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr. 2010 Apr;91(4):848-859.
  12. Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr. 2010;169:149-64.
  13. Gow RV, Val­lee-Tourangeau F, Crawford MA, et al. Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2013 Jun;88(6):411-8.
  14. Gustafsson PA, Bir­berg-Thornberg U, Duchén K, et al. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr. 2010 Oct;99(10):1540-1549.
  15. Milte CM, Parletta N, Buckley JD, et al. Increased Erythrocyte Eicosapen­taenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Random­ized Controlled Three-Way Crossover Trial. J Atten Disord. 2013 Nov 8.
  16. Milte CM, Sinn N, Buckley JD, et al. Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. J Child Health Care. 2011 Dec;15(4):299-311.
  17. Sorgi PJ, Hallowell EM, Hutchins HL, et al. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J. 2007;6:16.
  18. Yehuda S, Rabinovitz-Shenkar S, Carasso RL. Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children. Eur J Clin Nutr. 2011 Oct;65(10):1167-1169.
  19. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-defi­cit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991-1000.
  20. Yoon JR, Lee EJ, Kim HD, et al. Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy. Brain Dev. 2014 Feb;36(2):163-6.
  21. Furuhjelm C, Warstedt K, Larsson J, et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr. 2009;98:1461-7.
  22. Saadeh D, Salameh P, Baldi I, Raherison C. Diet and Allergic Diseases among Population Aged 0 to 18 Years: Myth or Reality? Nutrients. 2013 Aug 29;5(9):3399-423.
  23. Hageman JH, Hooyenga P, Diersen-Schade DA, et al. The impact of dietary long-chain polyunsaturated fatty acids on respiratory illness in infants and children. Curr Allergy Asthma Rep. 2012;12(6):564-73.
  24. Montgomery P. Omega-3 DHA and Children’s Sleep: New findings from the DOLAB Studies. Omega-3 DHA and Children’s Behaviour and Learning: New Insights from the ‘DOLAB’ Studies. 4 September 2013 – The Royal College of Sur­geons, London.
  25. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013 Oct 26;382(9902):1445-57.
  26. Skilton MR, Raitakari OT, Celermajer DS. High intake of dietary long-chain ω-3 fatty acids is associ­ated with lower blood pressure in children born with low birth weight: NHANES 2003-2008. Hypertension. 2013 May;61(5):972-6.
  27. Juárez-López C, Klünder-Klünder M, Madri­gal-Azcárate A, Flores-Huerta S. Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents. Pediatr Diabetes. 2013 Aug;14(5):377-83.
  28. Al-Farsi YM, Waly MI, Deth RC, et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-6.
  29. De Felice C, Cortelazzo A, Signorini C, et al. Effects of ω -3 polyunsaturated fatty acids on plasma proteome in Rett Syndrome. Mediators Inflamm. 2013;2013:723269.
  30. Amminger GP, Chanen AM, Ohmann S, et al. Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial. Can J Psychiatry. 2013 Jul;58(7):402-8.
  31. Mossaheb N, Schäfer MR, Schlögelhofer M, et al. Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective? Schizophr Res. 2013 Aug;148(1-3):163-7.
  32. Food and Agriculture Organization of the United Nations (FAO). 2010. Fats and fatty acids in human nutrition: Report of an expert consultation.
  33. National Institutes of Health, Office of Dietary Supplements.
  34. Eu­ropean Food Safety Authority. Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaeno­ic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal 2012;10(7):2815 [48 pp.].
  35. ExpertOmega3. Ácidos grasos omega-3 en supercritical concentration.
  36. ExpertOmega3. The Ethyl Ester vs. Triglyceride Form of Fish Oils.